New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
Trial ID or NCT#
Status
RECRUITING
Purpose
The purpose of this study is to compare the effects of ticagrelor and clopidogrel in patients with Peripheral Artery Disease.
Official Title
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Eligibility Criteria
- - Male and Female patients 50 years old or older Symptomatic peripheral artery disease
- - Patients needing dual anti-platlet drug treatment before start of study Planned revascularisation or amputation - Patients with known bleeding disorders - Patients with a history of intracranial bleed - Patients considered to be at risk of bradycardic events unless already treated with a permanent pacemaker
Contact us to find out if this trial is right for you.
CONTACT
AstraZeneca Clinical Study Information
(800) 236-9933
View on ClinicalTrials.gov
About this Clinical Trial
Your Message Will Go To
AstraZeneca Clinical Study Information800-236-9933